KR20200139876A - Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts - Google Patents

Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts Download PDF

Info

Publication number
KR20200139876A
KR20200139876A KR1020190066183A KR20190066183A KR20200139876A KR 20200139876 A KR20200139876 A KR 20200139876A KR 1020190066183 A KR1020190066183 A KR 1020190066183A KR 20190066183 A KR20190066183 A KR 20190066183A KR 20200139876 A KR20200139876 A KR 20200139876A
Authority
KR
South Korea
Prior art keywords
gastrointestinal diseases
health drink
manufacturing
improving gastrointestinal
cabbage
Prior art date
Application number
KR1020190066183A
Other languages
Korean (ko)
Other versions
KR102257052B1 (en
Inventor
조희환
Original Assignee
조희환
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 조희환 filed Critical 조희환
Priority to KR1020190066183A priority Critical patent/KR102257052B1/en
Publication of KR20200139876A publication Critical patent/KR20200139876A/en
Application granted granted Critical
Publication of KR102257052B1 publication Critical patent/KR102257052B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/02Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
    • A23L2/04Extraction of juices
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/70Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
    • A23L2/72Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/16Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by heating loose unpacked materials
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/21Plant extracts
    • A23V2250/2102Aloe
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/113Acidophilus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/125Casei
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/179Sakei
    • A23Y2220/03
    • A23Y2220/17
    • A23Y2220/77

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a method of manufacturing a healthy beverage containing cabbage for ameliorating gastrointestinal diseases. More particularly, the present invention relates to a method for manufacturing a healthy beverage for ameliorating gastrointestinal diseases, further comprising broccoli, aloe, apple, lemon, pineapple, licorice and Ulmus macrocarpa Hance. By removing a peculiar flavor that is generated when heating cabbage, it is possible to improve the taste and flavor, and it is also possible to improve digestion and ameliorate gastrointestinal diseases by including medicinal herbs.

Description

양배추를 포함하는 위장질환 개선용 건강음료의 제조방법{Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts}Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts

본 발명은 양배추를 포함하는 위장질환 개선용 건강음료의 제조방법에 관한 것으로, 보다 상세하게는 브로콜리, 알로에, 사과, 레몬, 파인애플, 감초 및 유근피를 추가로 포함하는 위장질환 개선용 건강음료의 제조방법에 관한 것이다.The present invention relates to a method of manufacturing a health drink for improving gastrointestinal diseases including cabbage, and in more detail, manufacturing a health drink for improving gastrointestinal diseases further comprising broccoli, aloe, apple, lemon, pineapple, licorice and yugeun peel It's about how.

일반적으로 건강즙은 대한민국에서 널리 애용되는 건강식품으로, 근래에는 음료의 개념으로 건강을 지키는 건강음료로 많이 애용되고 있다.In general, health juice is a widely used health food in Korea, and in recent years, it is widely used as a health drink to protect health as a concept of a beverage.

양배추(Brassica oleracea var. capitata)는 우리나라에서 가장 많이 소비되는 십자화과 채소 중 하나로 원산지는 지중해 연안이다. 양배추에는 수분 93.3%, 탄수화물 5.6%, 총 식이섬유 1.4%, 단백질 0.6%, 지방 0.1% 등이 함유되어 있으며, 탄수화물의 경우 프락토스 2.1%, 글루코스 1.8%, 수크로스 0.5% 등이 함유되어 양배추의 감미를 나타낸다. 또한, 필수지방산(linolenic acid)과 필수아미노산(lysine), 비타민 C, 비타민 K 등의 영양성분이 풍부한 것으로 알려져 있다. 양배추에 함유된 글루코시놀레이트(glucosinolate)는 암 예방, 면역기능 활성화, 항산화 효능 증가 등의 활성을 나타내며, S-메틸메티오닌(S-metylmethionine)은 항염증, 통증억제, 지방축적 억제 등의 효능이 보고되고 있다.Cabbage ( Brassica oleracea var. capitata) is one of the most consumed cruciferous vegetables in Korea and its origin is the Mediterranean coast. Cabbage contains 93.3% moisture, 5.6% carbohydrates, 1.4% total dietary fiber, 0.6% protein, and 0.1% fat.Carbohydrates contain 2.1% fructose, 1.8% glucose, and 0.5% sucrose. Represents the sweetness of. In addition, it is known to be rich in nutrients such as linolenic acid, essential amino acid (lysine), vitamin C, and vitamin K. Glucosinolate contained in cabbage exhibits activities such as preventing cancer, activating immune function, and increasing antioxidant efficacy, while S-methylmethionine is effective in anti-inflammatory, pain suppression, and fat accumulation. Is being reported.

브로콜리(Brassica oleracea var. italica)는 십자화과에 속하며 녹색꽃양배추라고도 한다. 지중해 동부와 소아시아가 원산지이고 온화한 기후에서 서늘한 기후까지 잘 자란다. 암 예방과 고혈압에 좋은 것으로 널리 알려진 브로콜리싹은 다 자란 것에 비해 항암물질인 '설포라판'이 최대 50배 더 들어있고 비타민 C의 함량도 레몬과 피망의 2배, 토마토의 8배가 들어있다고 알려져 있다.Broccoli ( Brassica oleracea var. italica) belongs to the cruciferous family and is also called green cauliflower. It is native to the eastern Mediterranean and Asia Minor and grows well from mild to cool climates. Broccoli sprouts, which are widely known to be good for cancer prevention and high blood pressure, contain up to 50 times more anti-cancer substance'sulforaphane' than fully grown, and are known to contain twice as much vitamin C as lemons and bell peppers, and 8 times as much as tomatoes.

알로에 베라(Aloe barbadensis Miller)는 백합과 알로에속의 일종인 다육식물이며, 여러 가지의 효능을 갖는 것이 경험적으로 알려져 있다. 알로에는 종류에 따라 다소의 차이는 있지만, 창과 같은 모양에 녹색 잎의 양 끝에는 가시가 있고 잎의 끝은 뾰족하다. 알로에의 주요한 성분은 육탄당을 포함하는 고분자 다당체, 알로에틴(aloetin), 알로에울신(aloe ulcin) 및 알로미틴 등이며, 이들 성분은 대부분 잎의 내부에 있는 겔 속에 존재한다고 알려져 있다.Aloe vera ( Aloe barbadensis Miller) is a succulent plant that is a kind of the lily family Aloe genus, and it is known empirically that it has various effects. Aloe is somewhat different depending on the type, but it has a spear-like shape, has thorns on both ends of the green leaf, and the tip of the leaf is sharp. The main components of aloe are high molecular polysaccharides containing hexose, aloetin, aloe ulcin, and alomitin, and most of these components are known to exist in gels inside leaves.

사과(Malus pumila)는 능금나무과에 속하는 우리나라의 대표적인 과일 중 하나로서, 대구, 충주, 예산 등이 주산지로서 홍옥, 국광, 인도, 후지가 주종을 이루고 있다. 식품학적 특성으로는 신맛에도 불구하고 알칼리성 식품이며, 중요한 성분은 당분, 유기산과 펙틴이다.Apple ( Malus pumila ) is one of Korea's representative fruits belonging to the family Alpsaceae. Daegu, Chungju, Yesan, etc. are the main production areas, and ruby, Gukgwang, India, and Fuji are the main species. In terms of food properties, it is an alkaline food despite its sour taste, and the important ingredients are sugar, organic acids and pectin.

레몬(Citrus limonia)은 운향과에 속하는 상록교목으로 인도와 서부 히말라야 원산으로 아열대 각 지역에서 재배된다. 과즙은 향기가 좋고 구연산과 비타민 C를 함유하여 음료나 향수 등에 널리 사용되고 있다.Lemon ( Citrus limonia ) is an evergreen tree belonging to the Unhyangdae family. It is native to India and the western Himalayas and is cultivated in each subtropical region. Fruit juice has a good scent and contains citric acid and vitamin C, so it is widely used in beverages and perfumes.

파인애플(Ananas comosus)은 당도가 높고 비타민 A, 비타민 C, 비타민 B가 많이 함유되어 있다. 신선한 과육을 그대로 먹거나 조리하여 섭취할 수 있다. 생리불순, 소화불량, 각기, 기생충, 신경성 피로 해소를 도와준다고 알려져 있으며, 과육은 약화된 피부를 온침시키는 효소로서 얼굴 마사지에 쓰일 수 있다.Pineapple ( Ananas comosus ) is high in sugar and contains a lot of vitamin A, vitamin C, and vitamin B. Fresh pulp can be eaten as it is or cooked and consumed. It is known to help relieve menstrual irregularities, indigestion, beriberi, parasites, and nervous fatigue, and pulp can be used for facial massage as an enzyme that warms weakened skin.

감초(Glycyrrhiza uralensis Fischer)는 약용식물이며, 뿌리는 적갈색으로 땅속 깊이들어가고 줄기는 모가지며 1m 정도 곧게 자란다. 또한, 흰털이 밀생하여 회백색으로 보이며 선점이 흩어져 있다. 꽃은 7~8월에 피는데 길이 1.4~2.5cm로 보라색이며, 뿌리는 단맛이 나서 감미료, 한약재로 사용할 수 있다.Licorice ( Glycyrrhiza uralensis Fischer) is a medicinal plant, and its roots are reddish brown, go deep into the ground, and the stems grow upright about 1m. In addition, the white hairs are dense, so it looks grayish and has scattered lines. Flowers bloom in July-August, 1.4-2.5cm long, purple, and the roots are sweet, so they can be used as a sweetener or herbal medicine.

유근피는 느릅나무(Ulmus macrocarpa Hance)의 뿌리껍질을 말린 것이다. 느릅나무는 우리나라 북부와 중부의 산기슭에서 자란다. 이른 봄과 가을에 뿌리를 캐 물에 씻은 다음 겉껍질은 버리고 속껍질을 벗겨 햇볕에 말려 제조할 수 있으며, 맛은 달고 성질은 평하다고 알려져 있다.The root bark of the elm tree ( Ulmus macrocarpa Hance) is dried. Elm trees grow in the foothills of the northern and central parts of Korea. It can be prepared by digging the roots in early spring and autumn and washing them in water, then discarding the outer shell and peeling the inner shell and drying it in the sun, and it is known for its sweet taste and flat properties.

최근 바쁜 현대 생활 속에서도 건강 증진을 목적으로 한 다양한 생리활성물질을 함유하는 건강음료의 선호도가 높아지고 있는데, 채소를 주재료로 하는 다양한 건강음료의 소비가 꾸준히 증대되고 있다.Despite the recent busy modern life, the preference of health drinks containing various physiologically active substances for the purpose of improving health is increasing, and consumption of various health drinks containing vegetables as the main ingredient is steadily increasing.

한국공개특허 제10-2018-0045444호에는 물을 첨가하지 않고 제조되는 양배추즙의 제조 방법에 관한 것으로 양배추를 주재료한 양배추즙의 제조방법이 개시되어 있고, 한국공개특허 제10-2017-0042890호에는 양배추, 브로콜리 및 진생베리를 이용한 건강 음료 제조방법이 개시되어 있으나, 본 발명의 양배추 특유의 맛과 향을 개선하고 위장질환의 효과를 나타내는 건강음료의 제조방법과는 상이하다.Korean Patent Laid-Open Publication No. 10-2018-0045444 relates to a method for producing cabbage juice prepared without adding water, and discloses a method for producing cabbage juice made mainly of cabbage. Korean Patent Publication No. 10-2017-0042890 However, a method of manufacturing a health drink using cabbage, broccoli, and ginseng berry is disclosed, but it is different from the method of manufacturing a health drink showing the effect of gastrointestinal disease and improving the taste and aroma of cabbage of the present invention.

한국공개특허 제10-2018-0045444호(발명의 명칭 : 물을 첨가하지 않은 양배추즙의 제조 방법, 출원인 : 주식회사 진성에프엠, 공개일자 : 2018.05.04.)Korean Patent Laid-Open Publication No. 10-2018-0045444 (Name of the invention: Method for manufacturing cabbage juice without water, Applicant: Jinsung FM Co., Ltd., Publication date: 2018.05.04.) 한국공개특허 제10-2017-0042890호(발명의 명칭 : 양배추, 브로콜리 및 진생베리를 이용한 건강 음료 제조방법, 출원인 : 농업회사법인 녹색식품(주), 공개일자 : 2017.04.20.)Korean Patent Laid-Open Patent No. 10-2017-0042890 (Name of the invention: Method for manufacturing health drinks using cabbage, broccoli and ginseng berry, Applicant: Green Food Co., Ltd., an agricultural corporation, Publication date: 2017.04.20.) 한국등록특허 제10-0908805호(발명의 명칭 : 건강음료의 제조방법 및 건강음료 조성물, 출원인 : 장남수, 등록일자 : 2009.07.15.)Korean Patent Registration No. 10-0908805 (Name of invention: method of manufacturing health drink and composition of health drink, applicant: Namsoo Jang, registration date: July 15, 2009)

본 발명의 목적은 양배추를 유효성분으로 포함하는 위장질환 개선용 건강음료의 제조방법을 제공하는 것으로, 보다 상세하게는 브로콜리, 알로에, 사과, 레몬, 파인애플, 감초 및 유근피를 추가로 포함하는 위장질환 개선용 건강음료의 제조방법을 제공하는데에 있다.An object of the present invention is to provide a method of manufacturing a health drink for improving gastrointestinal diseases containing cabbage as an active ingredient, and more particularly, gastrointestinal diseases further comprising broccoli, aloe, apple, lemon, pineapple, licorice and yugeunpi It is to provide a method of manufacturing a health drink for improvement.

본 발명은 양배추를 유효성분으로 포함하는 위장질환 개선용 건강음료의 제조방법에 관한 것이다.The present invention relates to a method of manufacturing a health drink for improving gastrointestinal diseases comprising cabbage as an active ingredient.

본 발명은 (제1단계) 채소, 과일 및 한약재를 절단 및 분쇄하고 혼합한 혼합물을 준비하는 단계;The present invention (first step) preparing a mixture of cutting and pulverizing and mixing vegetables, fruits and herbal medicines;

(제2단계) 제1단계의 혼합물에 발효 균주를 첨가하고 발효하여 발효물을 제조하는 단계;(Second step) preparing a fermented product by adding and fermenting a fermentation strain to the mixture of the first step;

(제3단계) 제2단계의 발효물을 가열추출하고 여과하여 추출물을 제조하는 단계;를 포함하는 것을 특징으로 하는 위장질환 개선용 건강음료의 제조방법에 관한 것이다.It relates to a method for manufacturing a health drink for improving gastrointestinal diseases, comprising a; (third step) heat-extracting and filtering the fermented product of the second step to prepare an extract.

상기 제1단계의 채소는 양배추(Brassica oleracea var. capitata), 브로콜리(Brassica oleracea var. italica) 및 알로에(Aloe barbadensis Miller), 과일은 사과(Malus pumila), 레몬(Citrus limonia) 및 파인애플(Ananas comosus), 한약재는 감초(Glycyrrhiza uralensis) 및 유근피(Ulmus macrocarpa Hance)인 것일 수 있다.Vegetables of the first step are cabbage ( Brassica oleracea var.capitata), broccoli ( Brassica oleracea var. italica) and aloe ( Aloe barbadensis Miller), fruits are apples ( Malus pumila ), lemon ( Citrus limonia ) and pineapple ( Ananas comosus ), the herbal medicine may be licorice ( Glycyrrhiza uralensis ) and Yugeunpi ( Ulmus macrocarpa Hance).

상기 제2단계의 발효 균주는 락토바실러스 사케이(Lactobacillus sakei), 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 카세이(Lactobacillus casei) 및 스트렙토코커스 락티스(Streptococcus lactis)의 혼합 균주인 것일 수 있다.The fermentation strain of the second step may be a mixed strain of Lactobacillus sakei , Lactobacillus acidophilus , Lactobacillus casei , and Streptococcus lactis . have.

상기 제3단계의 가열추출은 100 ~ 120℃에서 3 ~ 5시간 동안 열을 가하여 추출하는 것일 수 있다.The heat extraction in the third step may be extracted by applying heat at 100 to 120° C. for 3 to 5 hours.

상기 제3단계 이후, 추출물을 살균하는 포장하는 단계;가 추가될 수 있다.After the third step, packaging for sterilizing the extract; may be added.

상기 살균은 95 ~ 100℃에서 30분 ~ 2시간 동안 끓여서 실시하는 것일 수 있다.The sterilization may be performed by boiling at 95 to 100°C for 30 minutes to 2 hours.

또 다른 본 발명은 상기 제조방법에 따라 제조된 위장질환 개선용 건강음료에 관한 것이다.Another invention relates to a health drink for improving gastrointestinal diseases prepared according to the manufacturing method.

또한, 본 발명은 상기 건강음료 또는 이의 농축액, 이의 건조분말을 포함하는 것을 특징으로 하는 위장질환 개선용 약학 조성물에 관한 것이다.In addition, the present invention relates to a pharmaceutical composition for improving gastrointestinal diseases, characterized in that it comprises the health drink or a concentrate thereof, and a dry powder thereof.

또 다른 본 발명은 상기 건강음료 또는 이의 농축액, 이의 건조분말을 포함하는 것을 특징으로 하는 위장질환 개선용 건강기능식품에 관한 것이다.Another aspect of the present invention relates to a health functional food for improving gastrointestinal diseases, comprising the health drink or a concentrate thereof, and a dry powder thereof.

이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

상기 제1단계의 채소는 양배추(Brassica oleracea var. capitata), 브로콜리(Brassica oleracea var. italica) 및 알로에(Aloe barbadensis Mill.)일 수 있으며, 과일은 사과(Malus pumila), 레몬(Citrus limonia) 및 파인애플(Ananas comosus)일 수 있으며, 한약재는 감초(Glycyrrhiza uralensis) 및 유근피(Ulmus macrocarpa Hance)일 수 있다.Vegetables of the first step may be cabbage ( Brassica oleracea var. capitata), broccoli ( Brassica oleracea var. italica) and aloe ( Aloe barbadensis Mill.), and fruits are apples ( Malus pumila ), lemon ( Citrus limonia ) and Pineapple ( Ananas comosus ) may be, and the herbal medicine may be licorice ( Glycyrrhiza uralensis ) and Yugeunpi ( Ulmus macrocarpa Hance ).

또한, 상기 채소, 과일 및 한약재는 3 ~ 5㎝ 크기로 절단할 수 있으며, 채소 중 양배추와 브로콜리는 믹서기를 통해 분쇄할 수 있다. 추가로 과일은 씨를 제거하고 껍질째 또는 껍질을 벗겨 이용할 수 있으며, 이후 절단 및 분쇄된 채소, 과일 및 한약재를 모두 혼합하여 혼합물을 제조할 수 있다.In addition, the vegetables, fruits and medicinal herbs can be cut into 3 to 5 cm in size, and cabbage and broccoli among vegetables can be crushed through a blender. In addition, the fruit can be used by removing the seeds and peeling or peeling, and then the cut and pulverized vegetables, fruits, and herbal medicinal herbs are all mixed to prepare a mixture.

상기 혼합물은 양배추 100 중량부 기준 브로콜리 5 ~ 17 중량부, 알로에 1 ~ 7 중량부, 사과 1 ~ 5 중량부, 레몬 1 ~ 5 중량부, 파인애플 1 ~ 5 중량부, 감초 1 ~ 5 중량부 및 유근피 1 ~ 5 중량부를 혼합하여 제조한 것일 수 있다.The mixture includes 5 to 17 parts by weight of broccoli, 1 to 7 parts by weight of aloe, 1 to 5 parts by weight of apples, 1 to 5 parts by weight of lemon, 1 to 5 parts by weight of pineapple, 1 to 5 parts by weight of licorice, and It may be prepared by mixing 1 to 5 parts by weight of Yugeunpi.

상기 제2단계는 제1단계의 혼합물에 발효 균주를 첨가하고 발효하여 발효물을 제조하는 것일 수 있다.The second step may be to prepare a fermented product by adding and fermenting a fermentation strain to the mixture of the first step.

상기 발효 균주는 당업계에 공지된 다양한 유산균을 포함할 수 있다. 본 발명에서 이용되는 유산균은 락토바실러스 알리멘타리우스(Lactobacillus alimentarius), 락토바실러스 사케이(Lactobacillus sakei), 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 카세이(Lactobacillus casei), 락토바실러스 가세리(Lactobacillus gasseri), 락토바실러스 델브루엑키(Lactobacillus delbrueckii), 락토바실러스 퍼멘텀(Lactobacillus fermentum), 락토바실러스 불가리쿠스(Lactobacillus bulgaricus), 락토바실러스 헬베티쿠스(Lactobacillus helveticus), 류코노스톡 멘센테로이드스(Leuconostoc mensenteroides), 스트렙토코커스 서모필러스(Streptococcus thermophilus), 스트렙토코커스 락티스(Streptococcus lactis), 엔테로코커스 파에시엄(Enterococcus faecium), 엔테로코커스 파에칼리스(Enterococcus faecalis), 비피도박테리엄 비피덤(Bifidobacterium bifidum), 비피도박테리엄 인판티스(Bifidobacterium infantis), 비피도박테리엄 브라베(Bifidobacterium brave) 및 비피도박테리엄 롱검(Bifidobacterium longum)으로 구성된 군으로부터 선택되는 것일 수 있다.The fermentation strain may include various lactic acid bacteria known in the art. Lactobacillus used in the present invention is Lactobacillus alimentarius ( Lactobacillus alimentarius ), Lactobacillus sakei ( Lactobacillus sakei ), Lactobacillus acidophilus ), Lactobacillus casei ( Lactobacillus casei ), Lactobacillus casei Lactobacillus gasseri ), Lactobacillus delbrueckii , Lactobacillus fermentum , Lactobacillus bulgaricus ), Lactobacillus helveticus , Lactobacillus helvetic Leuconostoc mensenteroides), Streptococcus stand a brush Russ (Streptococcus thermophilus), Streptococcus lactis (Streptococcus lactis), Enterococcus par sieom (Enterococcus faecium), Enterococcus par faecalis (Enterococcus faecalis), Bifidobacterium William BP bonus (Bifidobacterium bifidum ) it may be selected from Bifidobacterium William Infante Tees (Bifidobacterium infantis), Bifidobacterium William Bra Entebbe (Bifidobacterium brave) and Bifidobacterium group consisting of Liam ronggeom (Bifidobacterium longum).

보다 바람직하게는 균주를 둘 이상 혼합하여 상기 혼합물에 첨가하여 발효할 수 있으며, 가장 바람직하게는 락토바실러스 사케이, 락토바실러스 아시도필러스, 락토바실러스 카세이 및 스트렙토코커스 락티스를 1:0.5~1:0.5~1:0.5~1의 중량비로 혼합한 균주를 첨가하여 발효하는 것이 좋다.More preferably, two or more strains may be mixed and added to the mixture for fermentation, and most preferably, Lactobacillus sakei, Lactobacillus acidophilus, Lactobacillus casey and Streptococcus lactis 1:0.5-1 It is recommended to ferment by adding the mixed strain at a weight ratio of :0.5~1:0.5~1.

한편, 발효는 30 ~ 37℃ 온도에서 12시간 ~ 3일간 실시할 수 있으며, 발효시 온도가 30℃ 미만이거나 시간이 12시간 미만이면 발효가 충분히 진행되지 않아 위장질환 개선의 효과를 나타내는 유효성분이 발생하지 않을 수 있어 바람직하지 못하며, 온도가 37℃ 초과이거나 시간이 3일 초과이면 경제적으로 바람직하지 못하다.On the other hand, fermentation can be carried out for 12 hours to 3 days at a temperature of 30 to 37°C. If the temperature is less than 30°C or the time is less than 12 hours during fermentation, the fermentation does not proceed sufficiently, resulting in an active ingredient showing the effect of improving gastrointestinal diseases It may not be preferable, and if the temperature exceeds 37°C or the time exceeds 3 days, it is not economically preferable.

제3단계에 있어서는 제2단계에서 제조한 발효물을 열수추출하고 여과하여 추출물을 제조할 수 있다. 보다 상세하게는 상기 발효물을 100 ~ 120℃에서 3 ~ 5시간 동안 추출하는 것이 바람직하며, 온도가 100℃ 미만이거나 3시간 미만이면 충분히 추출되지 않아 유효성분이 충분히 발생하지 않을 수 있으며, 온도가 120℃ 초과이거나 5시간 초과이면 경제적으로 바람직하지 못하다.In the third step, the fermented product prepared in the second step may be extracted with hot water and filtered to prepare an extract. In more detail, it is preferable to extract the fermented product at 100 to 120° C. for 3 to 5 hours, and if the temperature is less than 100° C. or less than 3 hours, the active ingredient may not be sufficiently generated because it is not sufficiently extracted, and the temperature is 120 It is economically unfavorable if it exceeds ℃ or exceeds 5 hours.

또한, 제3단계 이후, 상기 추출물을 살균하고 포장하는 단계를 실시할 수 있으며, 살균은 95 ~ 100℃에서 30분 ~ 2시간 동안 끓여서 실시하는 것일 수 있다.In addition, after the third step, the step of sterilizing and packaging the extract may be performed, and the sterilization may be performed by boiling at 95 to 100° C. for 30 minutes to 2 hours.

본 발명의 추출물은 동결건조하여 분말의 형태로 제조될 수 있으며, 또한 이를 포함하는 약학 조성물로 이용할 수 있다. 보다 상세하게는 다양한 경구 또는 비경구 투여 형태로 제형화할 수 있으나, 이에 한정하는 것은 아니다.The extract of the present invention may be freeze-dried to be prepared in the form of a powder, and may also be used as a pharmaceutical composition containing the same. In more detail, it may be formulated in various oral or parenteral dosage forms, but is not limited thereto.

경구 투여용 제형으로는 예를 들면 정제, 환제, 경/연질 캡슐제, 액제, 현탁제, 유화제, 시럽제, 과립제 등이 있는데, 이들 제형은 상기 유효성분 이외에 통상적으로 사용되는 충진제, 증량제, 습윤제, 붕해제, 활택제, 결합제, 계면 활성제 등의 희석제 또는 부형제를 1종 이상 사용할 수 있다. 붕해제로는 한천, 전분, 알긴산 또는 이의 나트륨염, 무수인산일수소 칼슘염 등이 사용될 수 있고, 활택제로는 실리카, 탈크, 스테아르산 또는 이의 마그네슘염 또는 칼슘염, 폴리에틸렌 글리콜 등이 사용될 수 있으며, 결합제로는 마그네슘, 알루미늄 실리케이트, 전분 페이스트, 젤라틴, 메틸셀룰로오스, 나트륨카복시메틸셀룰로오스, 폴리비닐피롤리딘, 저치환도 하이드록시프로필셀룰로오스, 글리신 등을 희석제로 사용할 수 있으며, 경우에 따라서는 일반적으로 알려진 비등 혼합물, 흡수제, 착색제, 향미제, 감미제 등을 함께 사용할 수 있다.Formulations for oral administration include, for example, tablets, pills, hard/soft capsules, solutions, suspensions, emulsifiers, syrups, granules, etc. These formulations include fillers, extenders, wetting agents, etc. that are commonly used in addition to the above active ingredients. One or more diluents or excipients such as disintegrants, lubricants, binders, and surfactants may be used. Agar, starch, alginic acid or its sodium salt, anhydrous monohydrogen phosphate calcium salt, etc. may be used as the disintegrant, and as the lubricant, silica, talc, stearic acid or its magnesium salt or calcium salt, polyethylene glycol, etc. may be used. , As a binder, magnesium, aluminum silicate, starch paste, gelatin, methylcellulose, sodium carboxymethylcellulose, polyvinylpyrrolidine, low-substituted hydroxypropylcellulose, glycine, etc. can be used as diluents, and in some cases, general A boiling mixture known as, absorbent, colorant, flavoring agent, sweetening agent, and the like may be used together.

또한, 비경구 투여는 피하주사제, 정맥주사제, 근육 내 주사제 또는 흉부 내 주사제를 주입하는 방법에 의한다. 이때 비경구 투여용 제형으로 제제화하기 위하여 양배추 추출물을 안정제 또는 완충제와 함께 물에서 혼합하여 용액 또는 현탁액으로 제조하고, 이를 앰플 또는 바이알의 단위 투여형으로 제조할 수 있다.In addition, parenteral administration is performed by injecting a subcutaneous injection, an intravenous injection, an intramuscular injection, or an intrathoracic injection. At this time, in order to formulate a formulation for parenteral administration, the cabbage extract is mixed in water with a stabilizer or buffer to prepare a solution or suspension, which can be prepared in a unit dosage form of an ampoule or vial.

상기 추출물은 멸균되거나 또는 방부제, 안정화제, 수화제 또는 유화 촉진제, 삼투압 조절을 위한 염, 완충제 등의 보조제 및 기타 치료적으로 유용한 물질을 함유할 수 있으며, 통상적인 방법인 혼합, 과립화 또는 코팅 방법에 따라 제제화할 수 있다. The extract may be sterilized or contain adjuvants such as preservatives, stabilizers, wetting agents or emulsification accelerators, salts for regulating osmotic pressure, buffers, and other therapeutically useful substances, which are conventional methods of mixing, granulating or coating. It can be formulated according to.

한편, 본 발명의 추출물 또는 이를 동결건조한 분말이 적용가능한 질환은 위장질환일 수 있다. 보다 구체적으로는 이에 제한되지는 않으나, 위장병, 위궤양, 십이지장궤양, 위염 또는 속쓰림, 역류성 식도염, 십이지장염, 소화불량, 위암일 수 있다.On the other hand, the disease to which the extract of the present invention or the lyophilized powder is applicable may be a gastrointestinal disease. More specifically, but not limited thereto, gastrointestinal disease, gastric ulcer, duodenal ulcer, gastritis or heartburn, reflux esophagitis, duodenitis, indigestion, gastric cancer.

본 발명은 양배추를 유효성분으로 포함하는 위장질환 개선용 건강음료의 제조방법에 관한 것이다. 추가로 알로에, 사과, 레몬 및 파인애플을 포함하여 양배추 가열시 발생하는 특유의 향을 제거함으로써 맛과 향을 개선하고, 소화를 향상시킬 수 있다. 또한, 위장질환의 염증을 감소시키는 한약재인 감초 및 유근피를 첨가하여 위장질환을 개선하는 효과를 나타낸다.The present invention relates to a method of manufacturing a health drink for improving gastrointestinal diseases comprising cabbage as an active ingredient. In addition, it is possible to improve taste and aroma and improve digestion by removing the characteristic aroma generated when heating cabbage including aloe, apple, lemon and pineapple. In addition, it shows the effect of improving gastrointestinal diseases by adding licorice and yugeunpi, which are herbal medicines that reduce inflammation of gastrointestinal diseases.

도 1은 본 발명에 따른 양배추를 유효성분으로 포함하는 위장질환 개선용 건강음료의 제조 순서도를 나타낸 것이다.1 is a flowchart illustrating a manufacturing flow chart of a health drink for improving gastrointestinal diseases comprising cabbage according to the present invention as an active ingredient.

이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지도록, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, it is provided to sufficiently convey the spirit of the present invention to those skilled in the art so that the contents introduced herein are thorough and complete.

실시예 1. 양배추를 포함하는 추출물의 제조Example 1. Preparation of extract containing cabbage

본 발명의 실시예에서는 양배추, 브로콜리, 알로에, 사과, 레몬, 파인애플, 감초 및 유근피를 이용하여 추출물을 제조하였다.In an example of the present invention, an extract was prepared using cabbage, broccoli, aloe, apple, lemon, pineapple, licorice and yugeun peel.

먼저 양배추, 브로콜리, 알로에, 사과, 레몬, 파인애플, 감초 및 유근피를 모두 깨끗이 세척한 후 재료를 모두 3 ~ 5cm 크기로 절단하였다. 과일은 씨를 제거하여 껍질째 이용하고, 양배추 및 브로콜리는 추가로 믹서기를 이용하여 분쇄한 후 모든 재료를 혼합하여 혼합물을 제조하였다. 상기 혼합물의 재료 조성은 하기 표 1에 나타내었다.First, cabbage, broccoli, aloe, apples, lemons, pineapples, licorice, and yugeun peel were all cleaned and cut into 3 ~ 5cm sized ingredients. The fruit was removed from the seeds and used as the skin, and cabbage and broccoli were further crushed using a blender, and all ingredients were mixed to prepare a mixture. The material composition of the mixture is shown in Table 1 below.

상기 혼합물 100g 기준 물 10g과 락토바실러스 사케이(Lactobacillus sakei), 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 카세이(Lactobacillus casei) 및 스트렙토코커스 락티스(Streptococcus lactis)를 각각 0.025g씩 혼합한 균주를 첨가하여 발효를 실시하였다. 발효는 35℃ 온도에서 1일간 실시하여 발효물을 제조하였다. 이후, 상기 발효물을 100℃에서 4시간 동안 열을 가하여 추출하여 추출물을 수득하였다.100 g of the mixture and Lactobacillus sakei ( Lactobacillus sakei ), Lactobacillus acidophilus ( Lactobacillus acidophilus ), Lactobacillus casei ( Lactobacillus casei ) and Streptococcus lactis ( Streptococcus lactis ) were mixed by 0.025 g each Fermentation was carried out by adding strain. Fermentation was carried out at a temperature of 35° C. for 1 day to prepare a fermented product. Thereafter, the fermented product was extracted by applying heat at 100° C. for 4 hours to obtain an extract.

구분division 양배추cabbage 브로콜리broccoli 알로에Aloe 사과Apple 레몬lemon 파인애플pineapple 감초licorice 유근피Yoo Geun-pi 총합total 실시예 1-1Example 1-1 100g100g 17g17g 4g4g 3g3g 2g2g 2g2g 3g3g 3g3g 134g134g 실시예 1-2Example 1-2 100g100g 14g14g 6g6g 5g5g 2g2g 3g3g 2g2g 2g2g 134g134g 실시예 1-3Example 1-3 100g100g 5g5g 7g7g 5g5g 2g2g 5g5g 5g5g 5g5g 134g134g 실시예 1-4Example 1-4 100g100g 8g8g 5g5g 2g2g 5g5g 5g5g 5g5g 4g4g 134g134g 실시예 1-5Example 1-5 100g100g 12g12g 3g3g 4g4g 4g4g 3g3g 4g4g 4g4g 134g134g

비교예 1. 재료의 조성을 다르게 하여 제조한 추출물의 제조Comparative Example 1. Preparation of extract prepared by different composition of materials

상기 실시예 1과 같은 방법으로 제조하되 재료의 조성을 다르게 하여 추출물을 제조하였다. 이를 하기 표 2에 나타내었다.The extract was prepared in the same manner as in Example 1, but the composition of the material was different. This is shown in Table 2 below.

구분division 양배추cabbage 브로콜리broccoli 알로에Aloe 사과Apple 레몬lemon 파인애플pineapple 감초licorice 유근피Yoo Geun-pi 총합total 비교예 1-1Comparative Example 1-1 100g100g 0g0g 9g9g 3g3g 7g7g 3g3g 8g8g 4g4g 134g134g 비교예 1-2Comparative Example 1-2 100g100g 20g20g 3g3g 5g5g 2g2g 2g2g 1g1g 1g1g 134g134g 비교예 1-3Comparative Example 1-3 100g100g 15g15g 0g0g 4g4g 5g5g 0g0g 5g5g 5g5g 134g134g 비교예 1-4Comparative Example 1-4 100g100g 11g11g 5g5g 0g0g 5g5g 8g8g 0g0g 5g5g 134g134g 비교예 1-5Comparative Example 1-5 100g100g 8g8g 4g4g 7g7g 5g5g 5g5g 5g5g 0g0g 134g134g 비교예 1-6Comparative Example 1-6 100g100g 3g3g 7g7g 4g4g 0g0g 14g14g 6g6g 0g0g 134g134g

비교예 2. 발효 과정을 다르게 한 추출물의 제조Comparative Example 2. Preparation of extract with different fermentation process

상기 실시예 1-1과 같은 방법으로 제조하되 발효 과정 중 발효 균주를 다르게 하거나 발효과정을 생략한 추출물을 제조하였으며 이를 하기 표 3에 나타내었다.The extract was prepared in the same manner as in Example 1-1, but with different fermentation strains during the fermentation process or omitting the fermentation process, and is shown in Table 3 below.

구 분division 내 용Contents 비교예 2-1Comparative Example 2-1 락토바실러스 사케이만을 이용하여 발효한 추출물Extract fermented using only Lactobacillus sakei 비교예 2-2Comparative Example 2-2 락토바실러스 사케이 및 락토바실러스 아시도필러스을 이용하여 발효한 추출물Extract fermented using Lactobacillus sakei and Lactobacillus acidophilus 비교예 2-3Comparative Example 2-3 락토바실러스 사케이, 락토바실러스 아시도필러스 및 락토바실러스 카세이를 이용하여 발효한 추출물Extract fermented using Lactobacillus Sake, Lactobacillus acidophilus and Lactobacillus Casey 비교예 2-4Comparative Example 2-4 락토바실러스 사케이 및 스트렙토코커스 락티스를 이용하여 발효한 추출물Extract fermented using Lactobacillus sakei and Streptococcus lactis 비교예 2-5Comparative Example 2-5 발효 과정을 생략하여 제조한 추출물Extract manufactured by omitting the fermentation process

실험예 1. 양배추 추출물의 위장질환 개선 효과 확인Experimental Example 1. Confirmation of gastrointestinal disease improvement effect of cabbage extract

헬리코박터균은 요소를 분해하는 효소인 우레아제(urease)를 생산하고 위 점막의 혈장 삼출액이나 조직액 내에 있는 요소를 분해하여 이산화탄소와 암모니아를 생성함으로써, 위 속의 강산을 중화하여 위에서 서식할 수 있는 것으로 알려져 있다. 따라서 헬리코박터균에 의한 위장질환의 증상을 개선시키기 위해서는 헬리코박터 우레아제 활성억제 능력이 있어, 환자가 섭취하였을 때 자연스럽게 헬리코박터의 생육을 억제할 수 있어야 한다.Helicobacter bacteria are known to produce carbon dioxide and ammonia by producing urease, an enzyme that degrades urea, and by decomposing urea in plasma exudate or tissue fluid of the gastric mucosa, thereby neutralizing strong acids in the stomach and inhabiting the stomach. . Therefore, in order to improve the symptoms of gastrointestinal diseases caused by Helicobacter bacteria, it has the ability to inhibit the activity of Helicobacter urease, and when ingested by the patient, it should be able to naturally suppress the growth of Helicobacter.

이에 따라 본 발명의 실시예 및 비교예에서 제조한 추출물에 대해 헬리코박터 우레아제 활성억제 효과 및 헬리코박터 항균능력을 확인하는 실험을 실시하였다.Accordingly, an experiment was conducted to confirm the inhibitory effect of Helicobacter urease activity and the antibacterial ability of Helicobacter with respect to the extracts prepared in Examples and Comparative Examples of the present invention.

실험예 1-1. 우레아제 활성억제 효과 확인Experimental Example 1-1. Confirmation of urease activity inhibition effect

본 실험예에서는 헬리코박터 우레아제 활성억제 효과를 확인하기 위하여 실험을 실시하였으며, 상기 헬리코박터는 표준균주(Helicobacter pylori ATCC 43504)를 사용하였다. 동결보관된 헬리코박터를 해동시켜 37℃, 습도 100%, CO2 10% 조건에서 3일간 배양하고, 항생제가 첨가되지 않는 동일배지에서 2일간 배양한 후 CO2 5%, O2 10%, N2 85%의 대기조건에서 교반하면서 24시간 동안 배양하였다.In this experimental example, an experiment was conducted to confirm the inhibitory effect of Helicobacter urease activity, and the Helicobacter pylori ATCC 43504 was used. Thaw frozen Helicobacter, incubate for 3 days at 37°C, 100% humidity, and 10% CO 2 , and incubate for 2 days in the same medium without antibiotics, and then CO 2 5%, O 2 10%, N 2 Incubated for 24 hours while stirring at 85% atmospheric condition.

그 후 균체를 수집하여, 인산 완충액으로 1회 세척하고 동일 완충액으로 현탁시켜 1분씩 6회 초음파처리(ultrasonication, Vibra Cell)한 후, 1,200rpm에서 1시간 동안 원심분리하여 우레아제를 분리하였다.Thereafter, the cells were collected, washed once with phosphate buffer, suspended in the same buffer, and sonicated 6 times for 1 minute (ultrasonication, Vibra Cell), and then centrifuged at 1,200 rpm for 1 hour to separate urease.

버퍼용액은 트리에탄올아민 2.984g을 증류수 900㎖에 첨가하고, 0.2N HCl로 pH가 6.7이 되도록 조정하여 총량이 1000㎖가 되도록 만들었다. 그 후 페놀 레드(Phenol red) 200㎎에 0.01N 수산화나트륨 28.2㎖를 첨가하고, 버퍼용액을 첨가하여 총량이 250㎖가 되도록 만든다. 우레아제 2㎎에 버퍼용액 5㎖를 넣어 사용하고, 요소액(urea)은 30mM로 준비하여 사용하였다.As a buffer solution, 2.984 g of triethanolamine was added to 900 ml of distilled water, and the pH was adjusted to 6.7 with 0.2N HCl, so that the total amount was 1000 ml. Then, 28.2 ml of 0.01N sodium hydroxide was added to 200 mg of phenol red, and a buffer solution was added to make the total amount 250 ml. 5 ml of a buffer solution was added to 2 mg of urease, and urea was prepared at 30 mM.

버퍼용액을 각각 시험관에 넣고 상기 실시예 1 및 비교예 1 내지 2에서 제조한 추출물을 0.2㎖씩 넣고 지시약을 0.3㎖씩 넣었다.Each buffer solution was put into a test tube, 0.2 ml of the extracts prepared in Example 1 and Comparative Examples 1 to 2 were added, and 0.3 ml of the indicator was added thereto.

25℃ 수욕조에 시험관을 담그고 우레아제를 30초 간격으로 넣고 5분 동안 반응시킨 후, 요소액을 0.5㎖씩 넣고 다시 5분 동안 반응시켜 555㎚에서 흡광도를 측정하였고, 하기식에 따라 활성억제 값을 환산하였다. 그 결과는 표 4에 나타내었다.The test tube was immersed in a 25°C water bath, urease was added at 30 second intervals, reacted for 5 minutes, 0.5 ml of urea solution was added and reacted for 5 minutes to measure the absorbance at 555 nm, and the activity inhibition value Was converted. The results are shown in Table 4.

활성억제(%) = 100×{1-(S-C2)/(C1-C2)}Inhibition of activity (%) = 100×{1-(S-C2)/(C1-C2)}

(S : 추출물로 처리한 우레아제의 흡광도, C2 : 변성 우레아제 흡광도,(S: absorbance of urease treated with extract, C2: absorbance of denatured urease,

C1 : 추출물로 처리하지 않은 우레아제의 흡광도)C1: absorbance of urease not treated with extract)

농도(1.0㎎/㎖)Concentration (1.0mg/ml) 우레아제 활성억제(%)Inhibition of urease activity (%) 실시예 1-1Example 1-1 72.872.8 실시예 1-2Example 1-2 71.271.2 실시예 1-3Example 1-3 70.770.7 실시예 1-4Example 1-4 71.371.3 실시예 1-5Example 1-5 69.069.0 비교예 1-1Comparative Example 1-1 44.744.7 비교예 1-2Comparative Example 1-2 43.143.1 비교예 1-3Comparative Example 1-3 41.741.7 비교예 1-4Comparative Example 1-4 40.940.9 비교예 1-5Comparative Example 1-5 38.038.0 비교예 1-6Comparative Example 1-6 42.242.2 비교예 2-1Comparative Example 2-1 31.231.2 비교예 2-2Comparative Example 2-2 33.333.3 비교예 2-3Comparative Example 2-3 38.938.9 비교예 2-4Comparative Example 2-4 34.734.7 비교예 2-5Comparative Example 2-5 28.628.6

표 4를 참고하면, 실시예 1-1 내지 1-5에서 제조한 추출물은 우레아제 활성억제율이 60% 이상을 나타내는 것을 확인할 수 있다. 이에 비해 비교예 1-1 내지 1-6에서 제조한 추출물은 우레아제 활성억제율이 45% 이하를 나타내며, 또한 비교예 2-1 내지 2-5에서 제조한 추출물은 우레아제 활성억제율이 40% 미만을 나타내어 보다 우레아제 활성억제 효과가 우수하지 못하다는 것을 알 수 있다.Referring to Table 4, it can be seen that the extracts prepared in Examples 1-1 to 1-5 have a urease activity inhibition rate of 60% or more. In contrast, the extracts prepared in Comparative Examples 1-1 to 1-6 exhibited a urease activity inhibition rate of 45% or less, and the extracts prepared in Comparative Examples 2-1 to 2-5 exhibited a urease activity inhibition rate of less than 40%. It can be seen that the urease activity inhibitory effect is not superior.

따라서, 본 실험에서는 양배추, 브로콜리, 알로에, 사과, 레몬, 파인애플, 감초 및 유근피의 추출물이 위장질환의 증상 개선을 위한 새로운 식품 소재로 사용될 수 있음을 확인하였고, 또한, 발효균주를 첨가하여 발효과정을 실시하였을 때 그 효과가가 더욱 우수해짐을 알 수 있었다.Therefore, in this experiment, it was confirmed that extracts of cabbage, broccoli, aloe, apple, lemon, pineapple, licorice, and yugeunpi can be used as a new food material for improving symptoms of gastrointestinal diseases. In addition, fermentation process by adding fermentation strains When implemented, it was found that the effect was more excellent.

실험예 1-2. 헬리코박터에 대한 항균활성 측정Experimental Example 1-2. Measurement of antibacterial activity against Helicobacter

상기 실시예 1 및 비교예 1 내지 2로부터 제조된 추출물에 대해 헬리코박터에 대한 항균활성 측정은 평판 디스크(paper disc afar diffusion)법을 사용하여 생성되는 억제환의 지름을 통해 확인하였다.Measurement of the antibacterial activity against Helicobacter for the extracts prepared from Example 1 and Comparative Examples 1 to 2 was confirmed through the diameter of the suppression ring produced by using a paper disc afar diffusion method.

브루셀라(brucella) 한천배지에서 48시간 배양된 헬리코박터 표준균주(Helicobacter pylori ATCC 43504)를 브루셀라 액상배지(Brucella broth)에 현탁하여 450㎚에서의 흡광도가 1.2가 되도록 하였다. 그리고 상기 현탁액 200㎕를 미리 준비된 브루셀라 한천배지에 도말한 후, 여기에 멸균된 필터 페이퍼 디스크(filter paper disc)(Tokyo, 8㎜, Japan)를 놓았다.The Helicobacter pylori ATCC 43504 cultured for 48 hours on Brucella agar medium was suspended in Brucella broth to have an absorbance of 1.2 at 450 nm. Then, 200 µl of the suspension was spread on a previously prepared Brucella agar medium, and then a sterilized filter paper disc (Tokyo, 8 mm, Japan) was placed thereon.

실시예 1 및 비교예 1 내지 2로부터 제조한 추출물을 0.45㎛ 막 여과기(membrane filter)로 여과하여 각 추출물의 최종농도가 1.0㎎/㎖가 되도록 한 후, 각각 10㎕씩 디스크에 흡수시켰다.The extracts prepared from Example 1 and Comparative Examples 1 to 2 were filtered through a 0.45 µm membrane filter so that the final concentration of each extract was 1.0 mg/ml, and then each 10 µl was absorbed into the disk.

10% CO2, 37℃ 조건에서 72시간 동안 배양한 후, 디스크 주위에 형성된 억제환(Clear zone)의 지름을 통해 각각의 항균활성 정도를 비교하였다. 그 결과는 표 5에 나타내었으며 억제환의 지름(㎜)은 디스크(disc) 크기(㎜)를 포함한 것이다.After incubating for 72 hours at 10% CO 2 and 37°C, the degree of antimicrobial activity was compared through the diameter of the clear zone formed around the disk. The results are shown in Table 5, and the diameter (mm) of the suppression ring includes the size of the disk (mm).

농도(1.0㎎/㎖)Concentration (1.0mg/ml) 억제환의 지름(㎜)Diameter of suppression ring (㎜) 실시예 1-1Example 1-1 17.417.4 실시예 1-2Example 1-2 16.516.5 실시예 1-3Example 1-3 16.816.8 실시예 1-4Example 1-4 17.117.1 실시예 1-5Example 1-5 16.716.7 비교예 1-1Comparative Example 1-1 9.99.9 비교예 1-2Comparative Example 1-2 8.68.6 비교예 1-3Comparative Example 1-3 9.19.1 비교예 1-4Comparative Example 1-4 9.89.8 비교예 1-5Comparative Example 1-5 8.88.8 비교예 1-6Comparative Example 1-6 8.68.6 비교예 2-1Comparative Example 2-1 7.47.4 비교예 2-2Comparative Example 2-2 8.08.0 비교예 2-3Comparative Example 2-3 7.87.8 비교예 2-4Comparative Example 2-4 7.77.7 비교예 2-5Comparative Example 2-5 6.36.3

상기 표 5를 참고하면, 실시예 1-1 내지 1-5에서 제조한 추출물은 억제환의 지름이 16㎜ 이상을 나타내는 반면, 재료의 조성을 다르게 하여 제조한 비교예 1-1 내지 1-5은 억제환의 지름이 10㎜ 미만으로 헬리코박터 균주에 대한 항균활성이 실시예 1-1 내기 1-5의 추출물이 더욱 우수하다는 것을 확인할 수 있다.Referring to Table 5, the extracts prepared in Examples 1-1 to 1-5 exhibited a diameter of 16 mm or more of the suppression ring, whereas Comparative Examples 1-1 to 1-5 prepared by varying the composition of the material were suppressed. It can be seen that the diameter of the ring is less than 10 mm, and the antibacterial activity against the Helicobacter strain is more excellent in the extract of Example 1-1 to 1-5.

또한, 발효과정을 다르게 하여 제조한 비교예 2-1 내지 2-5의 추출물은 더욱 억제환의 지름이 작게 형성된 것을 알 수 있어, 보다 실시예 1-1 내지 1-5에서 제조한 추출물이 헬리코박터에 대하여 강한 항균활성을 나타냄을 확인할 수 있었다.In addition, it can be seen that the extracts of Comparative Examples 2-1 to 2-5 prepared by different fermentation processes were formed with a smaller diameter of the inhibitory ring, and the extracts prepared in Examples 1-1 to 1-5 were added to Helicobacter. It was confirmed that it showed strong antibacterial activity.

따라서, 본 실험에서는 양배추, 브로콜리, 알로에, 사과, 레몬, 파인애플, 감초 및 유근피의 추출물이 위장질환의 증상 개선을 위한 새로운 식품 소재로 사용될 수 있음을 확인하였고, 또한, 발효균주를 첨가하여 발효과정을 실시하였을 때 그 효과가가 더욱 우수해짐을 알 수 있었다.Therefore, in this experiment, it was confirmed that extracts of cabbage, broccoli, aloe, apple, lemon, pineapple, licorice, and yugeunpi can be used as a new food material for improving symptoms of gastrointestinal diseases. In addition, fermentation process by adding fermentation strains When implemented, it was found that the effect was more excellent.

<제제예 1. 식품 제조><Formulation Example 1. Food production>

제제예 1-1. 조리용 양념의 제조Formulation Example 1-1. Preparation of cooking seasoning

본 발명의 실시예 1-1의 추출물을 동결건조한 동결건조물을 조리용 양념에 1 중량%로 첨가하여 건강 증진용 조리용 양념을 제조하였다.A freeze-dried product obtained by lyophilizing the extract of Example 1-1 of the present invention was added to the cooking seasoning in an amount of 1% by weight to prepare a cooking seasoning for health promotion.

제제예 1-2. 밀가루 식품의 제조Formulation Example 1-2. Manufacture of flour food

본 발명의 실시예 1-1의 추출물을 동결건조한 동결건조물을 밀가루에 0.1 중량%로 첨가하고, 이 혼합물을 이용하여 빵, 케이크, 쿠키, 크래커 및 면류를 제조하여 건강 증진용 식품을 제조하였다.A freeze-dried product obtained by lyophilizing the extract of Example 1-1 of the present invention was added to wheat flour in an amount of 0.1% by weight, and bread, cakes, cookies, crackers, and noodles were prepared using this mixture to prepare food for health promotion.

제제예 1-3. 스프 및 육즙(gravies)의 제조Formulation Example 1-3. Preparation of soups and gravies

본 발명의 실시예 1-1의 추출물을 동결건조한 동결건조물을 스프 및 육즙에 0.1 중량%로 첨가하여 건강 증진용 수프 및 육즙을 제조하였다.A lyophilized product obtained by lyophilizing the extract of Example 1-1 of the present invention was added to soups and broth in an amount of 0.1% by weight to prepare soups and juices for health promotion.

제제예 1-4. 유제품(dairy products)의 제조Formulation Example 1-4. Manufacture of dairy products

본 발명의 실시예 1-1의 추출물을 동결건조한 동결건조물을 우유에 0.1 중량%로 첨가하고, 상기 우유를 이용하여 버터 및 아이스크림과 같은 다양한 유제품을 제조하였다.A lyophilized product obtained by lyophilizing the extract of Example 1-1 of the present invention was added to milk in an amount of 0.1% by weight, and various dairy products such as butter and ice cream were prepared using the milk.

<제제예 2. 약학적 제제><Formulation Example 2. Pharmaceutical formulation>

제제예 2-1. 정제의 제조Formulation Example 2-1. Manufacture of tablets

본 발명의 실시예 1-1의 추출물을 동결건조한 동결건조물 200g을 락토오스 175.9g, 감자전분 180g 및 콜로이드성 규산 32g과 혼합하였다. 이 혼합물에 10% 젤라틴 용액을 첨가시킨 후, 분쇄해서 14 메쉬체를 통과시켰다. 이것을 건조시키고 여기에 감자전분 160g, 활석 50g 및 스테아린산 마그네슘 5g을 첨가해서 얻은 혼합물을 정제로 만들었다.200 g of a lyophilized product obtained by lyophilizing the extract of Example 1-1 of the present invention was mixed with 175.9 g of lactose, 180 g of potato starch, and 32 g of colloidal silicic acid. After adding a 10% gelatin solution to this mixture, it was pulverized and passed through a 14 mesh sieve. This was dried, and 160 g of potato starch, 50 g of talc and 5 g of magnesium stearate were added thereto, and the resulting mixture was made into tablets.

제제예 2-2. 주사액제의 제조Formulation Example 2-2. Preparation of injection solution

본 발명의 실시예 1-1의 추출물을 동결건조한 동결건조물 1g, 염화나트륨 0.6g 및 아스코르브산 0.1g을 증류수에 용해시켜서 100㎖를 만들었다. 이 용액을 병에 넣고 20℃에서 30분간 가열하여 멸균시켰다.1 g of a lyophilized product obtained by lyophilizing the extract of Example 1-1 of the present invention, 0.6 g of sodium chloride, and 0.1 g of ascorbic acid were dissolved in distilled water to make 100 ml. This solution was put in a bottle and sterilized by heating at 20° C. for 30 minutes.

Claims (9)

(제1단계) 채소, 과일 및 한약재를 절단 및 분쇄하고 혼합한 혼합물을 준비하는 단계;
(제2단계) 제1단계의 혼합물에 발효 균주를 첨가하고 발효하여 발효물을 제조하는 단계; 및
(제3단계) 제2단계의 발효물을 가열추출하고 여과하여 추출물을 제조하는 단계;를 포함하는 것을 특징으로 하는 위장질환 개선용 건강음료의 제조방법.
(Step 1) preparing a mixture obtained by cutting and pulverizing and mixing vegetables, fruits and medicinal herbs;
(Second step) preparing a fermented product by adding and fermenting a fermentation strain to the mixture of the first step; And
(3rd step) The method of manufacturing a health drink for improving gastrointestinal diseases comprising; heat-extracting and filtering the fermented product of the second step to prepare an extract.
제1항에 있어서,
상기 제1단계의 채소는 양배추(Brassica oleracea var. capitata), 브로콜리(Brassica oleracea var. italica) 및 알로에(Aloe barbadensis Miller), 과일은 사과(Malus pumila), 레몬(Citrus limonia) 및 파인애플(Ananas comosus), 한약재는 감초(Glycyrrhiza uralensis) 및 유근피(Ulmus macrocarpa Hance)인 것을 특징으로 하는 위장질환 개선용 건강음료의 제조방법.
The method of claim 1,
Vegetables of the first step are cabbage ( Brassica oleracea var.capitata), broccoli ( Brassica oleracea var. italica) and aloe ( Aloe barbadensis Miller), fruits are apples ( Malus pumila ), lemon ( Citrus limonia ) and pineapple ( Ananas comosus ), the herbal medicine is licorice ( Glycyrrhiza uralensis ) and yugeunpi ( Ulmus macrocarpa Hance), characterized in that the gastrointestinal disease improvement method of manufacturing a health drink.
제1항에 있어서,
상기 제2단계의 발효 균주는 락토바실러스 사케이(Lactobacillus sakei), 락토바실러스 아시도필러스(Lactobacillus acidophilus), 락토바실러스 카세이(Lactobacillus casei) 및 스트렙토코커스 락티스(Streptococcus lactis)의 혼합 균주인 것을 특징으로 하는 위장질환 개선용 건강음료의 제조방법.
The method of claim 1,
The fermentation strain of the second step is characterized in that it is a mixed strain of Lactobacillus sakei , Lactobacillus acidophilus , Lactobacillus casei and Streptococcus lactis . Method of manufacturing a health drink for improving gastrointestinal diseases.
제1항에 있어서,
상기 제3단계의 가열추출은 100 ~ 120℃에서 3 ~ 5시간 동안 열을 가하여 추출하는 것을 특징으로 하는 위장질환 개선용 건강음료의 제조방법.
The method of claim 1,
The heat extraction in the third step is a method of manufacturing a health drink for improving gastrointestinal diseases, characterized in that the extraction is performed by applying heat at 100 to 120°C for 3 to 5 hours.
제1항에 있어서,
상기 제3단계 이후, 추출물을 살균하고 포장하는 단계;가 추가되는 것을 특징으로 하는 위장질환 개선용 건강음료의 제조방법.
The method of claim 1,
After the third step, the step of sterilizing and packaging the extract; Method for producing a health drink for improving gastrointestinal diseases, characterized in that added.
제5항에 있어서,
상기 살균은 95 ~ 100℃에서 30분 ~ 2시간 동안 끓여서 실시하는 것을 특징으로 하는 위장질환 개선용 건강음료의 제조방법.
The method of claim 5,
The sterilization is a method for producing a health drink for improving gastrointestinal diseases, characterized in that boiled for 30 minutes to 2 hours at 95 ~ 100 ℃.
제1항의 제조방법에 따라 제조된 위장질환 개선용 건강음료.A health drink for improving gastrointestinal diseases prepared according to the manufacturing method of claim 1. 제7항의 건강음료 또는 이의 농축액, 이의 건조분말을 포함하는 것을 특징으로 하는 위장질환 개선용 약학 조성물.A pharmaceutical composition for improving gastrointestinal diseases, comprising the health drink of claim 7 or a concentrate thereof, and a dry powder thereof. 제7항의 건강음료 또는 이의 농축액, 이의 건조분말을 포함하는 것을 특징으로 하는 위장질환 개선용 건강기능식품.Health functional food for improving gastrointestinal diseases, characterized in that it comprises the health drink of claim 7 or a concentrate thereof, and a dry powder thereof.
KR1020190066183A 2019-06-04 2019-06-04 Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts KR102257052B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190066183A KR102257052B1 (en) 2019-06-04 2019-06-04 Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190066183A KR102257052B1 (en) 2019-06-04 2019-06-04 Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts

Publications (2)

Publication Number Publication Date
KR20200139876A true KR20200139876A (en) 2020-12-15
KR102257052B1 KR102257052B1 (en) 2021-05-27

Family

ID=73780378

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190066183A KR102257052B1 (en) 2019-06-04 2019-06-04 Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts

Country Status (1)

Country Link
KR (1) KR102257052B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102332497B1 (en) * 2021-02-18 2021-12-02 주식회사 지에스씨알오 Method for preparation of Cabbage Fermented Extracts containing Methyl Methionine Sulfonium Chloride by Lactobacillus delbrueckii KCTC3035

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102356427B1 (en) 2021-06-21 2022-02-08 농업법인 주식회사 우리팜 Functional lettuce beverage through mechanochemistry reaction and manufacturing method thereof
KR102317593B1 (en) 2021-06-21 2021-10-26 농업법인 주식회사 우리팜 Method for preparing activated lettuce solution through mechanochemistry reaction and cosmetic composition containing activated lettuce solution prepared therethrough

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426279B1 (en) * 2000-02-03 2004-04-08 주식회사 디히 Lactic acid bacterial fermentation products and manufacturing method thereof
KR100908805B1 (en) 2008-09-12 2009-07-21 장남수 The method for manufacturing of health drink
KR20140119401A (en) * 2013-04-01 2014-10-10 정용균 Cabbage extract using a method of manufacturing fermented cabbage juice
KR101595534B1 (en) * 2014-02-21 2016-02-18 재단법인 임실치즈과학연구소 Method for manufacturing fermented milk
KR20170042890A (en) 2015-10-12 2017-04-20 농업회사법인 녹색식품(주) process of manufacturing drinks
KR20180045444A (en) 2016-10-25 2018-05-04 주식회사 진성에프엠 Manufacturing method of cabbage juice without the addition of water

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426279B1 (en) * 2000-02-03 2004-04-08 주식회사 디히 Lactic acid bacterial fermentation products and manufacturing method thereof
KR100908805B1 (en) 2008-09-12 2009-07-21 장남수 The method for manufacturing of health drink
KR20140119401A (en) * 2013-04-01 2014-10-10 정용균 Cabbage extract using a method of manufacturing fermented cabbage juice
KR101595534B1 (en) * 2014-02-21 2016-02-18 재단법인 임실치즈과학연구소 Method for manufacturing fermented milk
KR20170042890A (en) 2015-10-12 2017-04-20 농업회사법인 녹색식품(주) process of manufacturing drinks
KR20180045444A (en) 2016-10-25 2018-05-04 주식회사 진성에프엠 Manufacturing method of cabbage juice without the addition of water

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102332497B1 (en) * 2021-02-18 2021-12-02 주식회사 지에스씨알오 Method for preparation of Cabbage Fermented Extracts containing Methyl Methionine Sulfonium Chloride by Lactobacillus delbrueckii KCTC3035

Also Published As

Publication number Publication date
KR102257052B1 (en) 2021-05-27

Similar Documents

Publication Publication Date Title
KR102257052B1 (en) Manufacturing method of healthy beverage containing improvement of gastric disease by using the cabbage extracts
KR101938315B1 (en) Method of manufacturing health food and beverage using Bacillus megaterium strain and its food and beverage
KR101705545B1 (en) Composition for preventing respiratorydisease, immune-enhancing, anti-obesity containing fermented Platycodon grandiflorum
CN104068109A (en) Ginger juice and red date yoghourt and preparation method thereof
KR101432584B1 (en) Method for steamed and fermented Codonopsis lanceolata for boosting biological activity
KR20120103917A (en) A method for preparing a pill or granule type fermented composition comprising the extract of complex herb useful in treating rheumatic disease
KR20220025679A (en) Method for producing fermented apple postbiotics with increased effective component content using lactic acid bacteria
KR20220136107A (en) Method for producing fermented product by lactic acid bacteria of Aloe with increased effective component content and postbioics products containing the same
KR20100003046A (en) An antibacterial composition comprising sun-dried salt and an extract of cudrania tricuspidata
KR102139732B1 (en) Composition for improving immune activity containing lactobacillus
TWI734322B (en) Kimchi for prevention or treatment of disease related to helicobacter pylori
KR101945207B1 (en) Method for manufacturing a composition for enhancing intestinal environment and composition manufactured by the method
KR20100029559A (en) A water composition comprising broussonetia kazinoki sieb. for immunopotentiating
KR102128602B1 (en) Raw Makgeolli Production Kit with Active Kimchi Lactobacillus
KR100512322B1 (en) Double-fermented bio-zyme liquid having an improvement effect of constipation
KR100977076B1 (en) Anti-helicobacter composition containing schizandra sp extract and rubus careabus extract
KR102064516B1 (en) An antibacterial composition comprising an leaf and root extract of cudrania tricuspidata, and extract of licorice
KR102342814B1 (en) Composition containing an fermented extract of protaetia brevitarsis seulensis as an active ingredient and manufacturing the same
KR102030902B1 (en) Fermentation method of lactic acid bacteria using fruit of Prunus sp. and its use
KR102210092B1 (en) Lactobacillus reuteri MG505 having anticariogenic activities and composition comprising the same
KR102138976B1 (en) Manufacturing Method for Fermentated and Aged Noni Powder
KR101282356B1 (en) Composition comprising Acanthopanacis Cortex butanol fraction for preventing or treating gastrointestinal disease
KR100707342B1 (en) Functional food using mulberry, leek and white clay and a method for producing thereof
KR20200039607A (en) A composition as a prebiotic for improving intestinal microflora containing sweet potato vines
KR20190071056A (en) Clathrate compound of Schisandra chinensis extract and method for its production

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant